Current and Emerging Biologic Therapies for Severe Asthma. [PDF]
Cazzola M +4 more
europepmc +1 more source
Chronic Rhinosinusitis With Nasal Polyps Successfully Treated With Tezepelumab After an Inadequate Response to Dupilumab: A Case Report. [PDF]
Wakasugi R +4 more
europepmc +1 more source
Biologic therapies for severe pediatric asthma: efficacy, safety, and biomarker-guided selection. [PDF]
Tondina E +8 more
europepmc +1 more source
Potential of alarmin-targeted bispecific and combination therapies in airway disease. [PDF]
Komori HK, Ortega H.
europepmc +1 more source
Respiratory Biologics Utilization, Prescription Predictors, and Outcomes in Patients With Asthma and Comorbid Overweight or Obesity. [PDF]
Foer D +5 more
europepmc +1 more source
Tezepelumab in Patients With Severe Asthma: Response at 3 Months
J C, Miralles-López +8 more
openaire +2 more sources
ERS Congress 2025: highlights from the Airway Diseases Assembly. [PDF]
Cefaloni F +13 more
europepmc +1 more source
Real-Life Indirect Case Matched Comparison of Dupilumab and Tezepelumab on Airway Oscillometry. [PDF]
Greig R, Chan R, Lipworth B.
europepmc +1 more source
Comparative efficacy of biologics for uncontrolled asthma patients with chronic rhinosinusitis or nasal polyps: a systematic review and network meta-analysis. [PDF]
Tsukada A +7 more
europepmc +1 more source
Airway epithelial dysfunction in asthma pathogenesis: epigenetic mechanisms, inflammatory crosstalk, and therapeutic opportunities. [PDF]
Zhang B, Song G, Sun M, Zhang Y, Ren M.
europepmc +1 more source

